anastrozole
IRB00081369
Phase 2 small_molecule active
Quick answer
anastrozole for Female Breast Carcinoma is a Phase 2 program (small_molecule) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Female Breast Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active